U.S. FDA expands approval of Roche hemophilia drug

Roche on Thursday said U.S. regulators approved expanded use of its hemophilia A drug Hemlibra to include nearly all patients, as the Swiss drugmaker increases its focus on diseases beyond cancer to help replace revenue from older products that have lost patent protection.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news